Table 1 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
UHL GP NEWS
Distribution of serum Kappa/Lambda FLC ratios (FLCr) reported by... | Download Scientific Diagram
Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on iStopMM Study
In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal
Final Diagnosis -- Case 701
Immunoglobulin Free Light Chains Kappa and Lambda Human ELISA | BioVendor R&D
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Distribution of serum FLC and kappa/lambda ratio in patients with renal... | Download Table